Disturbances in circadian rhythms often result in disturbancesin sleep. Examples include syndromes in which sleep time isdelayed or advanced, the sleeping problems associated with jetlag and shift work, and the sleep disorders that occur in totallyblind persons with free-running circadian rhythms (i.e., rhythmsthat are not synchronized to the 24-hour day).1 The hormonemelatonin can be used both to characterize and to treat suchdisorders.
The circadian rhythm of melatonin secretion is generated bythe central pacemaker, or "clock," in the suprachiasmatic nucleiof the hypothalamus, and like many other circadian rhythms,it is synchronized to . . . [Full Text of this Article]
References
This article has been cited by other articles:
Prada, C., Udin, S. B., Wiechmann, A. F., Zhdanova, I. V.
(2005). Stimulation of Melatonin Receptors Decreases Calcium Levels in Xenopus Tectal Cells by Activating GABAC Receptors. J. Neurophysiol.
94: 968-978
[Abstract][Full Text]
Rajaratnam, S. M. W, Middleton, B., Stone, B. M, Arendt, J., Dijk, D.-J.
(2004). Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans. J. Physiol.
561: 339-351
[Abstract][Full Text]
Campos, F. L., da Silva-Junior, F. P., de Bruin, V. M. S., de Bruin, P. F. C.
(2004). Melatonin Improves Sleep in Asthma: A Randomized, Double-blind, Placebo-controlled Study. Am. J. Respir. Crit. Care Med.
170: 947-951
[Abstract][Full Text]
Fischer, S., Smolnik, R., Herms, M., Born, J., Fehm, H. L.
(2003). Melatonin Acutely Improves the Neuroendocrine Architecture of Sleep in Blind Individuals. J. Clin. Endocrinol. Metab.
88: 5315-5320
[Abstract][Full Text]
Mutoh, T., Shibata, S., Korf, H.-W., Okamura, H.
(2003). Melatonin modulates the light-induced sympathoexcitation and vagal suppression with participation of the suprachiasmatic nucleus in mice. J. Physiol.
547: 317-332
[Abstract][Full Text]
Wolfler, A., Abuja, P. M., Linkesch, W., Schauenstein, K., Liebmann, P. M., Vijayalaxmi, , Thomas, C. R. Jr, Reiter, R. J., Herman, T. S.
(2002). Questionable Benefit of Melatonin for Antioxidant Pharmacologic Therapy. JCO
20: 4127-4129
[Full Text]
Masana, M. I., Dubocovich, M. L.
(2001). Melatonin Receptor Signaling: Finding the Path Through the Dark. Sci Signal
2001: pe39-pe39
[Abstract][Full Text]